Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/05/2026 | Q4 | $8.6B | -- | -- | $4.18 | -- |
| 10/31/2025 | Q3 | $8.6B | $8.6B | $4.09 | $4.18 | -$0.09 |
| 08/01/2025 | Q2 | $8.4B | $8.5B | $3.73 | $4.04 | -$0.31 |
| 05/01/2025 | Q1 | $8.3B | $8.1B | $3.51 | $3.92 | -$0.41 |
| 02/06/2025 | Q4 | $8.4B | $8.3B | $3.60 | $3.92 | -$0.32 |
| 10/31/2024 | Q3 | $8.3B | $8.4B | $3.22 | $3.91 | -$0.68 |
| 08/02/2024 | Q2 | $8.3B | $8.3B | $3.44 | $3.79 | -$0.34 |
| 05/02/2024 | Q1 | $8.4B | $8.1B | $3.35 | $3.67 | -$0.32 |
| 02/06/2024 | Q4 | $8.1B | $8.3B | $3.16 | $3.50 | -$0.34 |
| 10/26/2023 | Q3 | $8.6B | $8.2B | $3.19 | $3.57 | -$0.39 |
| 07/27/2023 | Q2 | -- | $8.2B | $3.19 | -- | -- |
| 04/27/2023 | Q1 | -- | $8.2B | $3.06 | -- | -- |
| 02/07/2023 | Q4 | -- | $7.9B | $2.67 | -- | -- |
| 10/27/2022 | Q3 | -- | $8.8B | $2.54 | -- | -- |
| 07/28/2022 | Q2 | -- | $8.5B | $0.74 | -- | -- |
| 04/28/2022 | Q1 | -- | $8.2B | $2.30 | -- | -- |
| 02/10/2022 | Q4 | -- | $8.3B | $1.99 | -- | -- |
| 10/28/2021 | Q3 | -- | $7.7B | $1.88 | -- | -- |
| 07/30/2021 | Q2 | -- | $7.6B | $1.61 | -- | -- |
| 05/06/2021 | Q1 | -- | $7.2B | $1.86 | -- | -- |
| 02/05/2021 | Q4 | -- | $7.3B | $1.46 | -- | -- |
| 11/05/2020 | Q3 | -- | $6.9B | $1.32 | -- | -- |
| 07/30/2020 | Q2 | -- | $6.4B | $0.87 | -- | -- |
| 05/07/2020 | Q1 | -- | $6.7B | $1.07 | -- | -- |
| 02/13/2020 | Q4 | -- | $7.1B | $0.94 | -- | -- |
| 11/12/2019 | Q3 | -- | $7B | $1.35 | -- | -- |
| 08/05/2019 | Q2 | -- | $7.2B | $0.96 | -- | -- |
| 05/10/2019 | Q1 | -- | $6.9B | $0.94 | -- | -- |
| 12/31/2018 | Q4 | -- | $5.8B | $6.46 | -- | -- |
| 11/10/2018 | Q3 | -- | $3B | $1.58 | -- | -- |
| 07/26/2018 | Q2 | -- | $3B | $1.65 | -- | -- |
| 04/26/2018 | Q1 | -- | $3B | $1.59 | -- | -- |
| 01/25/2018 | Q4 | -- | $3B | $0.11 | -- | -- |
| 10/26/2017 | Q3 | -- | $2.9B | $1.45 | -- | -- |
| 07/27/2017 | Q2 | -- | $2.8B | $1.41 | -- | -- |
| 04/27/2017 | Q1 | -- | $2.7B | $1.35 | -- | -- |
| 01/26/2017 | Q4 | -- | $2.6B | $1.41 | -- | -- |
| 10/27/2016 | Q3 | -- | $2.7B | $1.18 | -- | -- |
| 07/06/2016 | Q2 | -- | $2.7B | $1.39 | -- | -- |
| 04/29/2016 | Q1 | -- | $2.5B | $1.24 | -- | -- |
| 01/29/2016 | Q4 | -- | $2.6B | $1.47 | -- | -- |
Linde Plc reported $8.6B worth of top line sales in its most recent quarter.
Linde Plc announced earnings per share of $4.09 which represents a miss of analyst forecast a $4.18 per share.
Linde Plc reported $3.3B that represents $6.95 per share over the last quarter.
Linde Plc's earnings are forecast to grow from $13.62 per share to $15.47 per share next year representing an increase of 20.6%.
Linde Plc's next earnings date is February 5, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.